United States
US 12,702,676 B2
Fosfomycin dosing regimens
US 12,702,676 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: MEITHEAL PHARMACEUTICALS, INC. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- MEITHEAL PHARMACEUTICALS, INC.
- Inventors
- Evelyn Ellis-Grosse
- Publication date
- 2026-08-11
- Filing date
- 2023-01-03
- Document type
- B2 Granted patent
- Also written as
- US 12,702,676 B2 · US12702676 · 12702676
Abstract
Methods for identification of new dosing strategies which optimize positive treatment outcomes and patient safety. Specifically, new dosing strategies for fosfomycin and pharmaceutically acceptable salt thereof which have improved treatment outcomes in mammals. For example, a method of treating mammals having a bacterial infection with fosfomycin or a pharmaceutically acceptable salt thereof using improved dosing regimens.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free